RBC

Tekmira Pharmaceuticals (NASDAQ: TKMR) shares sank 15 percent after the company revealed the Phase I trial of one of its lead drug candidates was put on hold by the Food and Drug Administration for safety concerns. The anti-Ebola virus RNAi drug is being developed under a $140 million contract...

Shares of Gilead Sciences (NASDAQ: GILD) have fallen over four percent following Merck's (NYSE: MRK) purchase of Idenix Pharmaceuticals (NASDAQ: IDIX). Details on the Acquisition In a press release on Monday, Merck and Idenix announced that they have entered into a “definitive...

Zillow (NASDAQ: Z) shares have been volatile in Monday’s trading after RBC and Pacific Crest downgraded the company. RBC: Downgrade to Sector Perform From Outperform, Maintains $115 price Target Mark Mahaney of RBC noted that his fundamental analysis of Zillow remains in tact, but...

RBC upgraded Brookdale Senior Living (NYSE: BKD) to Top Pick from Outperform given the attractive fundamentals of the private-pay long-term care and BKD's industry-leading position, along with highly visible cash flow growth and strengthened by the pending Emeritus. RBC analyst Frank G. Morgan...

RBC on Monday upgraded Broadcom (NASDAQ: BRCM) to Outperform from Sector Perform. RBC analyst Doug Freedman believes the core business is undervalued given the expectation of $2.70 (BB+ING). Freedman states, "We think management is closely monitoring the progress of LTE investments and is...

RBC on Monday upgraded Altera (NASDAQ: ALTR) to Outperform from Sector Perform. RBC analyst Doug Freedman cited the upgrade due to sentiment "near a bottom given i) the expected lumpiness of revenues associated with the ramp of China LTE; and ii) a recently lowered GM outlook for ‘14." "We...

RBC on Monday upgraded NVIDIA (NASDAQ: NVDA) to Outperform from Sector Perform. RBC analyst Doug Freedman wrote the risk of near-term console revenue loss is removed, given the positive mix-shift focus of the company. Freedman continued to state, "NVDA's ability to leverage its past investments,...

RBC on Monday upgraded Micron Technology (NASDAQ: MU) to Outperform from Sector Perform as the firm believes Micron is to play longer-term on favorable changes in the memory industry. RBC analyst Doug Freedman backs the upgrade, stating, "On the DRAM side, higher margin levels are likely...

RBC on Monday upgraded Texas Instruments (NASDAQ: TXN) to Outperform based on a mix-shift that could accelerate free cash flow growth. RBC analyst Doug Freedman stated, "TXN is likely to benefit from positive mix-shifts, which should lift both gross margins and FCFs. The company has been laser...

3-D printing stocks are trading lower again in sympathy after ExOne (NASDAQ: XONE) reported downbeat fourth quarter results and issued a weak 2014 revenue outlook on Wednesday afternoon. Brean Capital sees the sector weakness as a sector buying opportunity and RBC had some bullish comments on the...